Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016 (2016), Article ID 1482194, 6 pages
http://dx.doi.org/10.1155/2016/1482194
Research Article

Vascular Endothelial Growth Factor Gene Polymorphism (rs2010963) and Its Receptor, Kinase Insert Domain-Containing Receptor Gene Polymorphism (rs2071559), and Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus

1Institute of Oncology Ljubljana, Zaloška 2, Sl-1000 Ljubljana, Slovenia
2Institute of Histology and Embryology, Faculty of Medicine, University in Ljubljana, Vrazov trg 2, Sl-1000 Ljubljana, Slovenia
3General Hospital Rakičan, Ulica dr. Vrbnjaka 6, Sl-9000 Murska Sobota, Slovenia
4General Hospital Slovenj Gradec, Gosposvetska Cesta 1, Sl-2380 Slovenj Gradec, Slovenia

Received 24 August 2015; Revised 24 October 2015; Accepted 1 November 2015

Academic Editor: Ronald G. Tilton

Copyright © 2016 Sebastjan Merlo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Laakso and J. Kuusisto, “Insulin resistance and hyperglycaemia in cardiovascular disease development,” Nature Reviews Endocrinology, vol. 10, no. 5, pp. 293–302, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. P. R. Moreno and V. Fuster, “New aspects in the pathogenesis of diabetic atherothrombosis,” Journal of the American College of Cardiology, vol. 44, no. 12, pp. 2293–2300, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Guasti, F. Marino, M. Cosentino et al., “Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: a longitudinal study,” Journal of Hypertension, vol. 24, no. 12, pp. 2423–2430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Marino, L. Guasti, M. Cosentino et al., “Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin,” Journal of Cardiovascular Pharmacology, vol. 49, no. 5, pp. 299–305, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Guasti, F. Marino, M. Cosentino et al., “Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up,” European Heart Journal, vol. 29, no. 9, pp. 1118–1126, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Khuseyinova and W. Koenig, “Biomarkers of outcome from cardiovascular disease,” Current Opinion in Critical Care, vol. 12, no. 5, pp. 412–419, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. P. N. Hopkins, “Molecular biology of atherosclerosis,” Physiological Reviews, vol. 93, no. 3, pp. 1317–1542, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Mócsai, “Diverse novel functions of neutrophils in immunity, inflammation, and beyond,” The Journal of Experimental Medicine, vol. 210, no. 7, pp. 1283–1299, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Baetta and A. Corsini, “Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives,” Atherosclerosis, vol. 210, no. 1, pp. 1–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Van Leeuwen, M. J. J. Gijbels, A. Duijvestijn et al., “Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR−/− mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 1, pp. 84–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Marino, M. Tozzi, L. Schembri et al., “Production of IL-8, VEGF and elastase by circulating and intraplaque neutrophils in patients with carotid atherosclerosis,” PLoS ONE, vol. 10, no. 4, Article ID e0124565, 2015. View at Publisher · View at Google Scholar
  12. T. Awata, K. Inoue, S. Kurihara et al., “A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes,” Diabetes, vol. 51, no. 5, pp. 1635–1639, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Petrovič, R. Verhovec, M. Globočnik Petrovič, J. Osredkar, and B. Peterlin, “Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes,” Cardiology, vol. 107, no. 4, pp. 291–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. G. Petrovič, P. Korošec, M. Košnik et al., “Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy,” Molecular Vision, vol. 14, pp. 1382–1387, 2008. View at Google Scholar · View at Scopus
  15. P. van der Meer, R. A. de Boer, H. L. White et al., “The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy,” Journal of Cardiac Failure, vol. 11, no. 4, pp. 279–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kariž and D. Petrovič, “Minor association of kinase insert domain-containing receptor gene polymorphism (rs2071559) with myocardial infarction in Caucasians with type 2 diabetes mellitus: case-control cross-sectional study,” Clinical Biochemistry, vol. 47, no. 16-17, pp. 192–196, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Douvaras, D. G. Antonatos, K. Kekou et al., “Association of VEGF gene polymorphisms with the development of heart failure in patients after myocardial infarction,” Cardiology, vol. 114, no. 1, pp. 11–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Alioglu, U. Turk, S. Cam, A. Abbasaliyev, I. Tengiz, and E. Ercan, “Polymorphisms of the methylenetetrahydrofolate reductase, vascular endothelial growth factor, endothelial nitric oxide synthase, monocyte chemoattractant protein-1 and apolipoprotein E genes are not associated with carotid intima-media thickness,” Canadian Journal of Cardiology, vol. 25, no. 1, pp. e1–e5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Kangas-Kontio, J. M. Tapanainen, H. Huikuri et al., “Variation in the vascular endothelial growth factor gene, carotid intima-media thickness and the risk of acute myocardial infarction,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 69, no. 3, pp. 335–343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Giannarelli, M. Alique, D. T. Rodriguez et al., “Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of HIF-1α and VEGF signaling,” Circulation, vol. 130, pp. 1274–1286, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Paternoster, N. A. Martinez-Gonzalez, R. Charleton, M. Chung, S. Lewis, and C. L. M. Sudlow, “Genetic effects on carotid intima-media thickness: systematic assessment and meta-analyses of candidate gene polymorphisms studied in more than 5000 subjects,” Circulation: Cardiovascular Genetics, vol. 3, no. 1, pp. 15–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Nikolajevic Starcevic, M. Santl Letonja, Z. J. Praznikar, J. Makuc, A. C. Vujkovac, and D. Petrovic, “Polymorphisms XbaI (rs693) and EcoRI (rs1042031) of the ApoB gene are associated with carotid plaques but not with carotid intima-media thickness in patients with diabetes mellitus type 2,” Vasa, vol. 43, no. 3, pp. 171–180, 2014. View at Google Scholar
  23. L. Rodríguez-Rodríguez, M. García-Bermúdez, C. González-Juanatey et al., “Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients,” Tissue Antigens, vol. 77, no. 4, pp. 291–297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. D. A. Russell, C. R. Abbott, and M. J. Gough, “Vascular endothelial growth factor is associated with histological instability of carotid plaques,” British Journal of Surgery, vol. 95, no. 5, pp. 576–581, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Eržen, M. Šilar, and M. Šabovič, “Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden,” BMC Cardiovascular Disorders, vol. 14, no. 1, pp. 166–170, 2014. View at Publisher · View at Google Scholar